Chronic running exercise alleviates early progression of nephropathy with upregulation of nitric oxide synthases and suppression of glycation in Zucker diabetic rats

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Ito, Daisuke ^a   Cao, Pengyu ^a   Kakihana, Takaaki ^a   Sato, Emiko ^b   Suda, Chihiro ^a   Muroya, Yoshikazu ^a   Ogawa, Yoshiko ^a   Hu, Gaizun ^a   Ishii, Tadashi ^a   Ito, Osamu ^a   Kohzuki, Masahiro ^a   Kiyomoto, Hideyasu ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; GLUCOSE; INSULIN; NITRIC OXIDE SYNTHASE; PROTEIN P47; THIOBARBITURIC ACID REACTIVE SUBSTANCE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVITY; FOOD INTAKE; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; GLYCATION; HOMEOSTASIS; INSULIN RELEASE; INTERSTITIAL NEPHRITIS; MALE; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; RUNNING; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE; TREATMENT RESPONSE; UPREGULATION; URINE VOLUME; ZUCKER DIABETIC FATTY RAT; ANIMAL; BLOOD PRESSURE; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; ZUCKER RAT;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; MALE; NITRIC OXIDE SYNTHASE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, ZUCKER;

EID: 84945902510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138037     Document Type: Article

References (42)

1. Teixeira-Lemos E, Nunes S, Teixeira F, Reis F. Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovascular diabetology. 2011; 10:12. Epub 2011/02/01. doi: 10.1186/1475-2840-10-12 PMID: 21276212; PubMed Central PMCID: PMC3041659.
2. Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: the global scenario. PloS one. 2013; 8(11):e80436. Epub 2013/11/16. doi: 10.1371/journal.pone.0080436 PMID: 24236181; PubMed Central PMCID: PMC3827454.
3. Muhammad AB, Lokhandwala MF, Banday AA. Exercise reduces oxidative stress but does not alleviate hyperinsulinemia or renal dopamine D1 receptor dysfunction in obese rats. American journal of physiology Renal physiology. 2011; 300(1):F98-104. Epub 2010/10/12. doi: 10.1152/ajprenal.00386. 2010 PMID: 20926629.
4. Boor P, Celec P, Behuliak M, Grancic P, Kebis A, Kukan M, et al. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats. Metabolism: clinical and experimental. 2009; 58(11):1669-77. Epub 2009/07/18. doi: 10.1016/j.metabol.2009.05.025 PMID: 19608208.
5. Rodrigues AM, Bergamaschi CT, Araujo RC, Mouro MG, Rosa TS, Higa EM. Effects of training and nitric oxide on diabetic nephropathy progression in type I diabetic rats. Exp Biol Med (Maywood). 2011; 236(10):1180-7. Epub 2011/09/21. doi: 10.1258/ebm.2011.011005 PMID: 21930716.
6. Kiraly MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, et al. Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. American journal of physiology Endocrinology and metabolism. 2008; 294(2):E271-83. Epub 2007/11/22. doi: 10.1152/ajpendo.00476.2007 PMID: 18029442.
7. Delghingaro-Augusto V, Decary S, Peyot ML, Latour MG, Lamontagne J, Paradis-Isler N, et al. Voluntary running exercise prevents beta-cell failure in susceptible islets of the Zucker diabetic fatty rat. American journal of physiology Endocrinology and metabolism. 2012; 302(2):E254-64. Epub 2011/11/03. doi: 10.1152/ajpendo.00360.2011 PMID: 22045312.
8. Kiraly MA, Campbell J, Park E, Bates HE, Yue JT, Rao V, et al. Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats. American journal of physiology Endocrinology and metabolism. 2010; 298(3): E671-82. Epub 2009/12/10. doi: 10.1152/ajpendo.90575.2008 PMID: 19996384.
9. Garvin JL, Herrera M, Ortiz PA. Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: clinical implications. Annual review of physiology. 2011; 73:359-76. Epub 2010/10/13. doi: 10.1146/annurev-physiol-012110-142247 PMID: 20936940.
10. Mount PF, Power DA. Nitric oxide in the kidney: functions and regulation of synthesis. Acta Physiol (Oxf). 2006; 187(4):433-46. Epub 2006/07/27. doi: 10.1111/j.1748-1716.2006.01582.x PMID: 16866775.
11. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. The Journal of clinical investigation. 1992; 90(1):278-81. Epub 1992/07/01. doi: 10.1172/JCI115849 PMID: 1634615; PubMed Central PMCID: PMC443093.
12. Fujihara CK, Mattar AL, Vieira JM Jr, Malheiros DM, Noronha Ide L, Goncalves AR, et al. Evidence for the existence of two distinct functions for the inducible NO synthase in the rat kidney: effect of aminoguanidine in rats with 5/6 ablation. Journal of the American Society of Nephrology: JASN. 2002; 13 (9):2278-87. Epub 2002/08/23. PMID: 12191972.
13. Kamijo H, Higuchi M, Hora K. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Nephron Physiology. 2006; 104(1):p12-22. Epub 2006/05/13. doi: 10.1159/000093276 PMID: 16691035.
14. Mattson DL, Wu F. Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension. 2000; 35(1 Pt 2):337-41. Epub 2000/01/21. PMID: 10642321.
15. Ito D, Ito O, Mori N, Muroya Y, Cao PY, Takashima K, et al. Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. Journal of hypertension. 2010; 28(11):2278-88. Epub 2010/08/21. PMID: 20724941.
16. Mori T, O'Connor PM, Abe M, Cowley AW Jr. Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk. Hypertension. 2007; 49 (6):1336-41. Epub 2007/05/02. doi: 10.1161/HYPERTENSIONAHA.106.085811 PMID: 17470722.
17. Tojo A, Onozato ML, Fujita T. Role of macula densa neuronal nitric oxide synthase in renal diseases. Medical molecular morphology. 2006; 39(1):2-7. Epub 2006/04/01. doi: 10.1007/s00795-006-0310-2 PMID: 16575507.
18. Agarwal D, Elks CM, Reed SD, Mariappan N, Majid DS, Francis J. Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats. Antioxidants & redox signaling. 2012; 16(2):139-52. Epub 2011/09/08. doi: 10.1089/ars.2011.3967 PMID: 21895524; PubMed Central PMCID: PMC3222098.
19. Ito D, Ito O, Cao P, Mori N, Suda C, Muroya Y, et al. Effects of exercise training on nitric oxide synthase in the kidney of spontaneously hypertensive rats. Clinical and experimental pharmacology & physiology. 2013; 40(2):74-82. Epub 2012/12/12. doi: 10.1111/1440-1681.12040 PMID: 23216343.
20. Ito D, Ito O, Mori N, Cao P, Suda C, Muroya Y, et al. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure. Clinical and experimental pharmacology & physiology. 2013; 40(9):617-25. Epub 2013/06/06. doi: 10.1111/1440-1681.12130 PMID: 23735016.
21. Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nature reviews Endocrinology. 2011; 7(3):176-84. Epub 2010/12/15. doi: 10.1038/nrendo.2010.212 PMID: 21151200.
22. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Current medicinal chemistry. 2010; 17(34):4256-69. Epub 2010/10/14. PMID: 20939814; PubMed Central PMCID: PMC3708695.
23. Kalyanaraman B. Teaching the basics of redox biology to medical and graduate students: Oxidants, antioxidants and disease mechanisms. Redox biology. 2013; 1:244-57. Epub 2013/09/12. doi: 10.1016/j.redox.2013.01.014 PMID: 24024158; PubMed Central PMCID: PMC3757692.
24. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? American journal of physiology Regulatory, integrative and comparative physiology. 2005; 289(4): R913-35. Epub 2005/09/27. doi: 10.1152/ajpregu.00250.2005 PMID: 16183628.
25. VanHoose L, Sawers Y, Loganathan R, Vacek JL, Stehno-Bittel L, Novikova L, et al. Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat. Cardiovascular diabetology. 2010; 9:56. Epub 2010/09/24. doi: 10.1186/1475-2840-9-56 PMID: 20860788; PubMed Central PMCID: PMC2954909.
26. Aref AB, Ahmed OM, Ali LA, Semmler M. Maternal rat diabetes mellitus deleteriously affects insulin sensitivity and Beta-cell function in the offspring. Journal of diabetes research. 2013; 2013:429154. Epub 2013/09/03. doi: 10.1155/2013/429154 PMID: 23998129; PubMed Central PMCID: PMC3753768.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry. 1976; 72:248-54. Epub 1976/05/07. PMID: 942051.
28. Nakayama K, Nakayama M, Iwabuchi M, Terawaki H, Sato T, Kohno M, et al. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. American journal of nephrology. 2008; 28(6):871-8. Epub 2008/06/13. doi: 10.1159/000139653 PMID: 18547947.
29. Pold R, Jensen LS, Jessen N, Buhl ES, Schmitz O, Flyvbjerg A, et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes. 2005; 54(4):928-34. Epub 2005/03/29. PMID: 15793229.
30. Lee S, Kuk JL, Davidson LE, Hudson R, Kilpatrick K, Graham TE, et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without Type 2 diabetes. J Appl Physiol (1985). 2005; 99(3):1220-5. Epub 2005/04/30. doi: 10.1152/japplphysiol.00053.2005 PMID: 15860689.
31. Winiarska K, Focht D, Sierakowski B, Lewandowski K, Orlowska M, Usarek M. NADPH oxidase inhibitor, apocynin, improves renal glutathione status in Zucker diabetic fatty rats: a comparison with melatonin. Chemico-biological interactions. 2014; 218:12-9. Epub 2014/05/07. doi: 10.1016/j.cbi.2014.04.005 PMID: 24797087.
32. Kohzuki M, Kamimoto M, Wu XM, Xu HL, Kawamura T, Mori N, et al. Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure. Journal of hypertension. 2001; 19(10):1877-82. Epub 2001/10/11. PMID: 11593110.
33. Tufescu A, Kanazawa M, Ishida A, Lu H, Sasaki Y, Ootaka T, et al. Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy. Journal of hypertension. 2008; 26(2):312-21. Epub 2008/01/15. PMID: 18192846.
34. Siwy J, Zoja C, Klein J, Benigni A, Mullen W, Mayer B, et al. Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles. PloS one. 2012; 7(12): e51334. Epub 2012/12/14. doi: 10.1371/journal.pone.0051334 PMID: 23236474; PubMed Central PMCID: PMC3517416.
35. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney international. 2000; 57(1):167-82. Epub 2000/01/05. doi: 10.1046/j.1523-1755.2000.00836.x PMID: 10620198.
36. Pruijm M, Wuerzner G, Maillard M, Bovet P, Renaud C, Bochud M, et al. Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2010; 25(7):2225-31. Epub 2010/02/04. doi: 10.1093/ndt/gfq008 PMID: 20124214.
37. Takenaka T, Inoue T, Okada H, Ohno Y, Miyazaki T, Chaston DJ, et al. Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes. Diabetologia. 2011; 54 (8):2192-201. Epub 2011/05/17. doi: 10.1007/s00125-011-2175-8 PMID: 21573906.
38. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proceedings of the National Academy of Sciences of the United States of America. 1994; 91(24):11704-8. Epub 1994/11/22. PMID: 7972128; PubMed Central PMCID: PMC45300.
39. Mizuno M, Sada T, Kato M, Koike H. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes. Hypertension research: official journal of the Japanese Society of Hypertension. 2002; 25(2):271-8. Epub 2002/06/06. PMID: 12047043.
40. Sofue T, Kiyomoto H, Kobori H, Urushihara M, Nishijima Y, Kaifu K, et al. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. American journal of hypertension. 2012; 25(5):604-11. Epub 2012/02/10. doi: 10.1038/ajh. 2012.1 PMID: 22318512; PubMed Central PMCID: PMC3328599.
41. Ihara G, Kiyomoto H, Kobori H, Nagai Y, Ohashi N, Hitomi H, et al. Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. Journal of hypertension. 2010; 28(11):2289-98. Epub 2010/08/14. PMID: 20706133; PubMed Central PMCID: PMC2955758.
42. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Inter., Suppl. 2012; 2:337-414. Available: http://www.kdigo.org/clinical-practice-guidelines/pdf/KDIGO-BP-GL.pdf